Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study.
Saved in:
| Title: | Erythrocytosis incidence and thromboembolic risk in heart failure with reduced ejection fraction treated with SGLT2 inhibitors: a nationwide register-based cohort study. |
|---|---|
| Authors: | Mohamed AA; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark. Abmoh06410@gmail.com., Andersen CF; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark., Christensen DM; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark., Riis-Vestergaard LD; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark., Mohammad M; Centre for Physical Activity Research, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark., Elmegaard M; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark., Binding C; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.; Department of Cardiology, Amager-Hvidovre University Hospital, Hvidovre, Denmark.; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark., Torp-Pedersen C; Department of Cardiology, Nordsjeallands Hospital, Hillerød, Denmark.; Department of Public Health, University of Copenhagen, Copenhagen, Denmark., Biering-Sørensen T; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Steno Diabetes Center Copenhagen, Copenhagen, Denmark.; Department of Biomedical Sciences, Faculty of Health and Medical Sciences, Center for Translational Cardiology and Pragmatic Randomized Trials, University of Copenhagen, Copenhagen, Denmark., Hansen ML; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark., Køber L; Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Glenthøj A; Department of Hematology, Danish Red Blood Cell Center, Copenhagen University Hospital, Copenhagen, Denmark., Jensen J; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark., Andersson C; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.; Section of Cardiovascular Medicine, Department of Medicine, Center for Advanced Heart Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Gislason G; Department of Cardiology, Herlev-Gentofte University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. |
| Source: | Cardiovascular diabetology [Cardiovasc Diabetol] 2025 Aug 01; Vol. 24 (1), pp. 314. Date of Electronic Publication: 2025 Aug 01. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1475-2840 |
|---|---|
| DOI: | 10.1186/s12933-025-02871-w |
